The role of fatty acid elongation in epidermal structure and function

Dermato-Endocrinology

Volumn 3, Issue 2, 2011, Pages 65-69

  Uchida, Yoshikazu ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ceramide; Epidermal barrier; Fatty acid; Fatty acid elongation; Stratum corneum; Very long chain fatty acid

Indexed keywords

VERY LONG CHAIN FATTY ACID;

BIOSYNTHESIS; EPIDERMIS; FATTY ACID SYNTHESIS; HUMAN; HYDROXYLATION; NONHUMAN; PERMEABILITY BARRIER; REVIEW; SKIN FUNCTION; SKIN PERMEABILITY; SKIN STRUCTURE;

EID: 79956158944     PISSN: 19381972     EISSN: 19381980     Source Type: Journal    
DOI: 10.4161/derm.3.2.14662     Document Type: Review

References (55)

1. Elias PM, Menon GK. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 1991; 24:1-26.
2. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38:441-6.
3. Aveldano MI, Sprecher H. Very long chain (C24 to C36) polyenoic fatty acids of the n-3 and n-6 series in dipolyunsaturated phosphatidylcholines from bovine retina. J Biol Chem 1987; 262:1180-6. (Pubitemid 17028432)
4. Sharp P, Johnson D, Poulos A. Molecular species of phosphatidylcholine containing very long chain fatty acids in human brain: enrichment in X-linked adrenoleukodystrophy brain and diseases of peroxisome biogenesis brain. J Neurochem 1991; 56:30-7. (Pubitemid 21901926)
5. Grogan WM. Metabolism of arachidonate in rat testis: characterization of 26-30 carbon polyenoic acids. Lipids 1984; 19:341-6. (Pubitemid 14076245)
6. Poulos A, Sharp P, Johnson D, Easton C. The occurrence of polyenoic fatty acids with greater than 22 carbon atoms in mammalian spermatozoa. Biochem J 1986; 240:891-5. (Pubitemid 17010012)
7. Leonard AE, Pereira SL, Sprecher H, Huang YS. Elongation of long-chain fatty acids. Prog Lipid Res 2004; 43:36-54. (Pubitemid 37433866)
8. Jakobsson A, Westerberg R, Jacobsson A. Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog Lipid Res 2006; 45:237-49.
9. Moon YA, Horton JD. Identification of two mammalian reductases involved in the two-carbon fatty acyl elongation cascade. J Biol Chem 2003; 278:7335-43. (Pubitemid 36800736)
10. Ikeda M, Kanao Y, Yamanaka M, Sakuraba H, Mizutani Y, Igarashi Y, et al. Characterization of four mammalian 3-hydroxyacyl-CoA dehydratases involved in very longchain fatty acid synthesis. FEBS Lett 2008; 582:2435-40.
11. Aveldano MI. A novel group of very long chain polyenoic fatty acids in dipolyunsaturated phosphatidylcholines from vertebrate retina. J Biol Chem 1987; 262:1172-9. (Pubitemid 17028431)
12. Furland NE, Oresti GM, Antollini SS, Venturino A, Maldonado EN, Aveldaño MI. Very long-chain polyunsaturated fatty acids are the major acyl groups of sphingomyelins and ceramides in the head of mammalian spermatozoa. J Biol Chem 2007; 282:18151-61. (Pubitemid 47100232)
13. Rabionet M, van der Spoel AC, Chuang CC, von Tümpling-Radosta B, Litjens M, Bouwmeester D, et al. Male germ cells require polyenoic sphingolipids with complex glycosylation for completion of meiosis: a link to ceramide synthase-3. J Biol Chem 2008; 283:13357-69.
14. Uchida Y, Hara M, Nishio H, Sidransky E, Inoue S, Otsuka F, et al. Epidermal sphingomyelins are precursors for selected stratum corneum ceramides. J Lipid Res 2000; 41:2071-82. (Pubitemid 32039003)
15. Ohno Y, Suto S, Yamanaka M, Mizutani Y, Mitsutake S, Igarashi Y, et al. ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis. Proc Natl Acad Sci USA 2010; 107:18439-44.
16. Burr GO, Burr MM. On the Nature and Role of Fatty Acids Essential in Nutrition. J Biol Chem 1930; 86:587-621.
17. Gray GM, White RJ, Majer JR. 1-(3′-O-acyl)-betaglucosyl-N- dihydroxypentatriacontadienoylsphingosine, a major component of the glucosylceramides of pig and human epidermis. Biochim Biophys Acta 1978; 528:127-37.
18. Wertz PW, Downing DT. Ceramides of pig epidermis: structure determination. J Lipid Res 1983; 24:759-65.
19. Bowser PA, Nugteren DH, White RJ, Houtsmuller UM, Prottey C. Identification, isolation and characterization of epidermal lipids containing linoleic acid. Biochim Biophys Acta 1985; 834:419-28. (Pubitemid 15025250)
20. Bouwstra JA, Ponec M. The skin barrier in healthy and diseased state. Biochim Biophys Acta 2006; 1758:2080-95. (Pubitemid 44879362)
21. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 1991; 96:523-6.
22. Yamamoto A, Serizawa S, Ito M, Sato Y. Stratum corneum lipid abnormalities in atopic dermatitis. Archives for Dermatological Research. Archiv fur Dermatologische Forschung 1991; 283:219-23.
23. Di Nardo A, Wertz P, Giannetti A, Seidenari S. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Dermato-Venereologica 1998; 78:27-30. (Pubitemid 28103674)
24. Rogers J, Harding C, Mayo A, Banks J, Rawlings A. Stratum corneum lipids: the effect of ageing and the seasons. Arch Dermatol Res 1996; 288:765-70. (Pubitemid 26388135)
25. Paige DG, Morse-Fisher N, Harper JI. Quantification of stratum corneum ceramides and lipid envelope ceramides in the hereditary ichthyoses. Br J Dermatol 1994; 131:23-7. (Pubitemid 24234283)
26. Uchida Y, Cho Y, Moradian S, Kim J, Nakajima K, Crumrine D, et al. Neutral lipid storage leads to acylceramide deficiency, likely contributing to the pathogenesis of Dorfman-Chanarin syndrome. J Invest Dermatol 2010; 130:2497-9.
27. Zhang K, Kniazeva M, Han M, Li W, Yu Z, Yang Z, et al. A 5 bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat Genet 2001; 27:89-93. (Pubitemid 32044525)
28. Vasireddy V, Uchida Y, Salem N Jr, Kim SY, Mandal MN, Reddy GB, et al. Loss of functional ELOVL4 depletes very long-chain fatty acids (≥C28) and the unique {omega}-Oacylceramides in skin leading to neonatal death. Hum Mol Genet 2007; 16:471-82. (Pubitemid 46522611)
29. McMahon A, Butovich IA, Mata NL, Klein M, Ritter R 3rd, Richardson J, et al. Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4. Mol Vis 2007; 13:258-72. (Pubitemid 46323316)
30. Li W, Sandhoff R, Kono M, Zerfas P, Hoffmann V, Ding BC, et al. Depletion of ceramides with very long chain fatty acids causes defective skin permeability barrier function, and neonatal lethality in ELOVL4 deficient mice. Int J Biol Sci 2007; 3:120-8. (Pubitemid 46232773)
31. Radner FP, Streith IE, Schoiswohl G, Schweiger M, Kumari M, Eichmann TO, et al. Growth retardation, impaired triacylglycerol catabolism, hepatic steatosis and lethal skin barrier defect in mice lacking comparative gene identification-58 (CGI-58). J Biol Chem 2010; 285:7300-11.
32. Ujihara M, Nakajima K, Yamamoto M, Teraishi M, Uchida Y, Akiyama M, et al. Epidermal triglyceride levels are correlated with severity of ichthyosis in Dorfman-Chanarin syndrome. J Dermatol Sci 2010; 57:102-7.
33. Uchida Y, Holleran WM. Omega-O-acylceramide, a lipid essential for mammalian survival. J Dermatol Sci 2008; 51:77-87.
34. Wertz PW, Madison KC, Downing DT. Covalently bound lipids of human stratum corneum. J Invest Dermatol 1989; 92:109-11. (Pubitemid 19027702)
35. Uchida Y, Behne M, Quiec D, Elias PM, Holleran WM. Vitamin C stimulates sphingolipid production and markers of barrier formation in submerged human keratinocyte cultures. J Invest Dermatol 2001; 117:1307-13. (Pubitemid 34205934)
36. Hamanaka S, Nakazawa S, Yamanaka M, Uchida Y, Otsuka F. Glucosylceramide Accumulates Preferentially in Lamellar Bodies in Differentiated Keratinocytes. Br J Dermatol 2005; 152:426-34. (Pubitemid 40547115)
37. Moon YA, Hammer RE, Horton JD. Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice. J Lipid Res 2009; 50:412-23.
38. Matsuzaka T, Shimano H, Yahagi N, Kato T, Atsumi A, Yamamoto T, et al. Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. Nat Med 2007; 13:1193-202. (Pubitemid 47530641)
39. Westerberg R, Tvrdik P, Undén AB, Månsson JE, Norlén L, Jakobsson A, et al. Role for ELOVL3 and fatty acid chain length in development of hair and skin function. J Biol Chem 2004; 279:5621-9. (Pubitemid 38220589)
40. Pewzner-Jung Y, Ben-Dor S, Futerman AH. When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: Insights into the regulation of ceramide synthesis. J Biol Chem 2006; 281:25001-5. (Pubitemid 44401887)
41. Holleran WM, Takagi Y, Uchida Y. Epidermal sphingolipids: Metabolism, function and role(s) in skin disorders. FEBS Letters 2006; 23:5456-66. (Pubitemid 44465907)
42. Mizutani Y, Mitsutake S, Tsuji K, Kihara A, Igarashi Y. Ceramide biosynthesis in keratinocyte and its role in skin function. Biochimie 2009; 91:784-90.
43. Ternes P, Franke S, Zähringer U, Sperling P, Heinz E. Identification and characterization of a sphingolipid delta 4-desaturase family. J Biol Chem 2002; 277:25512-8. (Pubitemid 34951866)
44. Stewart ME, Downing DT. A new 6-hydroxy-4-sphingenine-containing ceramide in human skin. J Lipid Res 1999; 40:1434-9. (Pubitemid 29379983)
45. Hamanaka S, Nakazawa S, Yamanaka M, Uchida Y, Otsuka F. Glucosylceramide accumulates preferentially in lamellar bodies in differentiated keratinocytes. Br J Dermatol 2005; 152:426-34. (Pubitemid 40547115)
46. Behne M, Uchida Y, Seki T, de Montellano PO, Elias PM, Holleran WM. Omega-hydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function. J Invest Dermatol 2000; 114:185-92. (Pubitemid 30195993)
47. Wertz PW, Downing DT. Metabolism of linoleic acid in porcine epidermis. J Lipid Res 1990; 31:1839-44. (Pubitemid 20387352)
48. Stone SJ, Myers HM, Watkins SM, Brown BE, Feingold KR, Elias PM, et al. Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. J Biol Chem 2004; 279:11767-76. (Pubitemid 38401682)
49. Oda Y, Uchida Y, Moradian S, Crumrine D, Elias PM, Bikle DD. Vitamin D Receptor and Coactivators SRC2 and 3 Regulate Epidermis-Specific Sphingolipid Production and Permeability Barrier Formation. J Invest Dermatol 2008; 129:1367-78.
50. Jakobsson A, Jorgensen JA, Jacobsson A. Differential regulation of fatty acid elongation enzymes in brown adipocytes implies a unique role for Elovl3 during increased fatty acid oxidation. Am J Physiol Endocrinol Metab 2005; 289:517-26.
51. Wang Y, Botolin D, Christian B, Busik J, Xu J, Jump DB. Tissue-specific, nutritional and developmental regulation of rat fatty acid elongases. J Lipid Res 2005; 46:706-15. (Pubitemid 43073280)
52. Jorgensen JA, Zadravec D, Jacobsson A. Norepinephrine and rosiglitazone synergistically induce Elovl3 expression in brown adipocytes. Am J Physiol Endocrinol Metab 2007; 293:1159-68.
53. Qin Y, Dalen KT, Gustafsson JA, Nebb HI. Regulation of hepatic fatty acid elongase 5 by LXRalpha-SREBP-1c. Biochim Biophys Acta 2009; 1791:140-7.
54. Robson KJ, Stewart ME, Michelsen S, Lazo ND, Downing DT. 6-Hydroxy-4-sphingenine in human epidermal ceramides. J Lipid Res 1994; 35:2060-8. (Pubitemid 24353078)
55. Motta S, Monti M, Sesana S, Caputo R, Carelli S, Ghidoni R. Ceramide composition of the psoriatic scale. Biochim Biophys Acta 1993; 1182:147-51. (Pubitemid 23267037)